Deep Bio said it signed a partnership with Visiopharm, a Danish pharmaceutical company, to supply DeepDx Prostate, its deep learning-based prostate cancer pathology image analysis software. Under the agreement, Deep Bio will be able to...

Deep Bio: Demonstrated globally-recognized standards in safety and quality management as a medical software manufacturer SEOUL, SOUTH KOREA (PRWEB) AUGUST 16, 2022 Deep Bio, a pioneer in medical AI for pathologic cancer diagnostics, announced...

Aiforia Technologies Plc is thrilled to announce it received CE-IVD marking for the Aiforia® Clinical Suite Viewer, a cloud-based platform enabling a holistic approach to cancer diagnostics and prognostics through the viewing of whole slide...

Oslo, Norway - DoMore Diagnostics, a leader in cancer outcome prediction with pathology AI algorithms, today announced that it has achieved CE-IVD mark for the Histotype Px  Colorectal, a deep learning algorithm that predict patient outcome...

ALBUQUERQUE, NM – May 24, 2022 – Indica Labs, the leading provider of computational pathology software and services, is excited to announce a CE-IVD Mark for HALO Prostate AI, a deep learning-based screening tool designed to assist...

LAUSANNE, Switzerland and ALBUQUERQUE, N.M. – May 12, 2022 – 5 pm (CET) | 9 am MDT – Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Indica Labs, a leading provider of...